NATCO-CITALOPRAM

natco pharma (canada) inc🇨🇦 Health Canada

Approval Id: 962a7b621eaa720d
Drug Approval Canada Name: NATCO-CITALOPRAM
Product Name: NATCO-CITALOPRAM
Status: Marketed
Status Date: 2023-09-18
Original Market Date: 2023-09-18
Din: 02443880
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 28:16.04.20
Atc Original: N06AB04 CITALOPRAM
Atc Name: n 06 ab 04
Aig Number: 0136243001
Company Name: natco pharma (canada) inc
Company Address: 2000 Argentia Road, Plaza 1, Suite 200, Mississauga, Ontario, Canada, L5N 1P7

CITALOPRAM (CITALOPRAM HYDROBROMIDE)

20 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

962a7b621eaa720d

Type

Standard